Form 4 for RMTI ROCKWELL MEDICAL, INC.
Accepted 2025-05-21 00:00:00 ET · period of report 2025-05-20 · accession 0001104659-25-051706 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-05-21 | 2025-05-20 | RMTI | Neri Jesse | SVP, Fin AND CFO | A - Grant | $0.00 | +97.5K | 127.5K | +325% | $0 |
| D | 2025-05-21 | 2025-05-20 | RMTI | Neri Jesse | SVP, Fin AND CFO | A - Grant | $0.00 | +195.0K | 195.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-20 | A | A | 97,500 | $0.00 | 127,500 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2025-05-20 | A | A | 195,000 | $0.00 | 195,000 | D | $1.07 · — to 2035-05-20 | 195,000 Common Stock | (F2) Stock options vest 1/3 on the first anniversary of May 20, 2025, with the remaining vesting in equal monthly installments through May 20, 2028, subject to the Reporting Person's continued service to the Issuer. |